Pseudouridine modification in Caenorhabditis elegans spliceosomal snRNAs: unique modifications are found in regions involved in snRNA-snRNA interactions
© Patton and Padgett; licensee BioMed Central Ltd. 2005
Received: 18 July 2005
Accepted: 19 October 2005
Published: 19 October 2005
Pseudouridine (Ψ) is an abundant modified nucleoside in RNA and a number of studies have shown that the presence of Ψ affects RNA structure and function. The positions of Ψ in spliceosomal small nuclear RNAs (snRNAs) have been determined for a number of species but not for the snRNAs from Caenorhabditis elegans (C. elegans), a popular experimental model system of development.
As a prelude to determining the function of or requirement for this modification in snRNAs, we have mapped the positions of Ψ in U1, U2, U4, U5, and U6 snRNAs from worms using a specific primer extension method. As with other species, C. elegans U2 snRNA has the greatest number of Ψ residues, with nine, located in the 5' half of the U2 snRNA. U5 snRNA has three Ψs, in or near the loop of the large stem-loop that dominates the structure of this RNA. U6 and U1 snRNAs each have one Ψ, and two Ψ residues were found in U4 snRNA.
The total number of Ψs found in the snRNAs of C. elegans is significantly higher than the minimal amount found in yeasts but it is lower than that seen in sequenced vertebrate snRNAs. When the actual sites of modification on C. elegans snRNAs are compared with other sequenced snRNAs most of the positions correspond to modifications found in other species. However, two of the positions modified on C. elegans snRNAs are unique, one at position 28 on U2 snRNA and one at position 62 on U4 snRNA. Both of these modifications are in regions of these snRNAs that interact with U6 snRNA either in the spliceosome or in the U4/U6 small nuclear ribonucleoprotein particle (snRNP) and the presence of Ψ may be involved in strengthening the intermolecular association of the snRNAs.
Pseudouridine (Ψ) is an abundant modified nucleoside found in RNA, at one time considered the fifth nucleoside of RNA . This modification has been found in many types of RNA and is particularly abundant in small stable RNAs such as transfer RNA (tRNA) and small nuclear RNA (snRNA) [2, 3]. Because of its structure, with the carbon at the 5 position of the uracil ring attached to the sugar rather than the nitrogen at the 1 position, Ψ is potentially more versatile in its hydrogen bonding interactions . The presence of Ψ appears to strengthen stems in RNA secondary structures and to stabilize base stacking in loops [5–7]. The splicing of pre-messenger RNAs (pre-mRNAs) in Xenopus oocytes is dependent on the presence of Ψ in U2 snRNA [8, 9]. This requirement for Ψ in U2 snRNA was also seen in mammalian splicing extracts [10, 11]. In addition, structural studies indicate that Ψ at a particular position in U2 snRNA is necessary to obtain the proper conformation of the pre-mRNA:U2 snRNA interaction during splicing [12–14]. The presence of Ψ at position 34 in human U2 snRNA enhances the formation of a splicing intermediate found when an RNA oligonucleotide containing the lariat branch point of the pre-mRNA is incubated with in vitro transcribed U2 and U6 snRNA segments .
The formation of Ψ is catalyzed by pseudouridine synthases after transcription and a number of site-specific synthases have been characterized from eukaryotes for the modification of tRNAs [16–22]. It has been shown that the pseudouridylation of several of the residues in metazoan snRNAs require small nucleolar RNA cofactors (snoRNAs) [23–25]. In yeast the formation of Ψ in U2 snRNA is accomplished by a combination of site-specific Ψ synthases [22, 26, 27] and a synthase that is RNA cofactor dependent .
The nucleotides that are modified to Ψ in the spliceosomal snRNAs (U1, U2, U4, U5 and U6 snRNA) have been completely mapped for two species of yeast [26, 29] and rat . In addition, the modifications in several of the spliceosomal snRNAs have been sequenced for other species such as fruit fly, frog, humans, and plants (for review see ). The positions that are pseudouridylated are, for the most part, conserved and nearly all of the Ψs appear in the 5' half of the snRNAs [3, 29, 30]. The systematic mapping of the sites of pseudouridylation on these essential splicing cofactors has not been attempted for one of the most popular model systems currently used in biology, Caenorhabditis elegans (C. elegans). This is especially surprising given the fact that cis-splicing in C. elegans exhibits a number of differences from other species. For example, there is a highly conserved 3' acceptor site and a lack of an identified lariat branch point consensus sequence within introns [31, 32].
In this report we present the results of the mapping of the sites of Ψ modification on the spliceosomal snRNAs of C. elegans, the first step in a larger endeavor to determine the factors required for the formation of Ψ in worms and the function(s) of these modifications in an animal model of development. All of the C. elegans spliceosomal snRNAs contain Ψ, which distinguishes these results from those seen with the snRNAs from two yeast species [26, 29]. C. elegans U2 snRNA is the most highly modified with a total of nine Ψs, all in the first 56 nucleotides of the snRNA. U5 snRNA has three Ψ residues in the highly conserved stem-loop known to be essential for pre-mRNA splicing. C. elegans U4 snRNA has two Ψs, with one in a region of the snRNA that participates in an RNA-RNA interaction with U6 snRNA and allows for the formation of the U4/U6 small nuclear ribonucleoprotein particle (snRNP). U1 and U6 snRNAs each have one Ψ identified. When the sites of modification are compared with snRNAs sequenced from other species, two of the positions modified on C. elegans snRNAs are unique, one at position 28 on U2 snRNA and one at position 62 on U4 snRNA. These modifications are in regions of each snRNA that are predicted to interact with U6 snRNA to form the U4/U6 snRNP or in the spliceosome during the removal of introns from pre-mRNA .
A primer extension method [34, 35] was used to identify the positions of Ψ in the snRNAs. The method involves chemically treating the total RNA from wild type worms with 1-cyclohexyl-3(2-morpholinoethyl) carbodi-imide metho-p-toluenesulphonate (CMCT) which covalently reacts with uridines, and other nucleotides, whether modified or not. Two concentrations of CMCT were used in the reactions and the reaction was allowed to proceed such that only a portion of the available uridines is covalently modified. This partial reaction is important since it is essential to be able to extend the primer past the first Ψ encountered in order to identify additional Ψs. The isolated total RNA is then treated with mild base, and as a consequence only the Ψ residues are left covalently modified. This covalent modification of Ψ creates a stop to reverse transcriptase (RT) progression during the specific primer extension phase of the assay. The products are electrophoresed on a 10% polyacrylamide/8.3 M urea gel along with sequencing lanes using the same end-labeled primer. When bands appear in the CMCT+ lanes but not in the CMCT- lanes and those bands are just prior to a uridine in the sequence, then there is a Ψ at that position.
Nearly all of the Ψ residues that have been mapped on any snRNA of any species are found in the 5' half of the RNA [3, 30], the exceptions being one residue found near the 3' end of U6 snRNA (rat, mouse, bean) and two residues that are found at positions 131 and 132 on Drosophila U4 snRNA. Therefore this primer extension technique [34, 35] can be used to determine the modification state of all but the very 3' 18 nucleotides of the snRNA. To map the positions of Ψ on C. elegans snRNAs, primers that hybridized to the extreme 3' end of each snRNA were used initially. Three additional primers were used to map sites of modification on U2 snRNA, and two additional primers were used to map U4, U5, and U6 snRNAs. Only one additional primer was used to map modifications on U1 snRNA.
U4 snRNAs from other species that have been sequenced have from zero to five Ψs [3, 29]. Two Ψs were identified on C. elegans U4 snRNA mapped with the U4RevB primer (Fig. 1B). They occur at positions 62 and 72, with stops to RT appearing in the CMCT treated lanes of the gel. Pseudouridines have been found at positions 4, 72, and 79 in all vertebrate U4 snRNAs sequenced, but no other U4 snRNA sequenced has a Ψ at position 62 . The possible modifications of the uridine at positions 79 and 80 of C. elegans U4 snRNA, slightly obscured in a region of stops to RT progression even in the CMCT- lane, are marked on the figure. However, the use of additional primers in the assay has not confirmed Ψs at these positions (data not shown). With this specific primer extension method  there is a possibility of misidentifying Ψs , so since this is a region of considerable secondary structure, the conservative interpretation of the data was that there are no Ψs at these sites. No modification of uridines near the 5' end of C. elegans U4 snRNA, such as at position 4 (Fig. 1B), was observed with this or another primer (U4RevC), that is closer to the 5' end of the U4 snRNA (data not shown).
One Ψ was mapped on U6 snRNA from C. elegans at position 26 (Fig. 3B), which is equivalent to position 31 in the vertebrate U6 snRNA numbering system. This position is modified in mammals but not in either yeast U6 snRNA mapped [26, 29]. A second primer (U6RevC, data not shown) was used to confirm the lack of modification at position 35, which corresponds to a Ψ in mammalian U6 snRNA (position 40). Based on the sequences of other U6 snRNAs  there is a possibility that there might be another Ψ residue close to the 3' end of the C. elegans U6 snRNA (at position 81). Since even the most 3' primer we used in these assays would hybridize to this position, we were not able to determine if worm U6 snRNA has this modification using this technique.
In yeast, Pus1p modifies one position on U2 snRNA , but when total RNA from CePus1p knockout worms (VC110, see Experimental section) was used as template for the primer extensions with U1RevB, U5RevC, and U6RevC primers there was no difference in the Ψ modification pattern seen with wild type (N2) and VC110 RNA (data not shown). This result was also seen with U2 snRNA from VC110 worms, and was reported previously .
In all the snRNAs that have been sequenced and the modifications determined, U2 snRNA has by far the most Ψs. C. elegans U2 snRNA has nine, less than the number seen with vertebrates and flowering plants but greater than the number seen with either S. pombe or S. cerevisiae . The overall modification pattern seen with C. elegans U2 snRNA is unique, and there is one position that is modified to Ψ that is not found in the U2 snRNAs from other species (position 28). The other eight modifications were found at sites that have previously been identified as sites of pseudouridylation in U2 snRNA and two (positions 41 and 43 in rat U2 snRNA) have been found in all U2 snRNAs mapped . These modifications have been implicated in the function of the pre-mRNA splicing cofactor [8–11]. It was shown by an in vitro reconstitution system for pre-mRNA splicing that the modified U2 snRNA reconstituted splicing but U2 snRNA without Ψs did not [10, 11]. In addition, modifications at the 5' end of U2 snRNA were shown to be necessary for the cofactor's activity in the reconstitution of pre-mRNA splicing in Xenopus oocytes . Using this same system, Zhao and Yu  have recently shown that the presence of Ψ in the region of U2 snRNA (nts. 34–46) that interacts with the pre-mRNA lariat branch point is required for function of the cofactor and for the formation of the active 17S U2 small nuclear ribonucleoprotein particle (snRNP).
The 'branch point interacting region' of U2 snRNA is highly pseudouridylated, with six modifications in vertebrates and V. faba, five in S. pombe and 3 in S. cerevisiae . All of these species have U2 snRNAs that have Ψ at positions 34, 41, and 43. C. elegans also has five Ψs in this region, and although there are Ψs at positions equivalent to 41 and 43, we were unable to detect a modification at the position equivalent to 34 (C. elegans position 36). The sequence of this region is highly conserved , and so even though there is a uridine at position 36 in the U2 snRNA from C. elegans, it does not appear to be converted to Ψ. This is a surprising result given the importance attached to the presence of Ψ at this position. It is the nucleotide that is predicted to be directly across from the bulged adenosine in the helix formed by U2 snRNA and pre-mRNA in mammalian and yeast splicing mechanisms . Newby and Greenbaum have shown that the presence of Ψ at this position stabilizes the bulged adenosine conformation in oligomers, which is predicted to be favorable for splicing [12–14]. In addition, Valadkhan and Manley have shown that in vitro, a Ψ at position 34 in U2 snRNA enhances the formation of a putative splicing intermediate between U2 and U6 snRNAs . It has been shown recently that when the loss of Pseudouridine synthase 7 (Pus7p), responsible for Ψ35 in S. cerevisiae U2 snRNA (the Ψ34 equivalent), is coupled with the mutation of position 40 in U2 snRNA (a U to G substitution or the deletion of the U), a synthetic growth defect is seen. Neither the loss of Pus7p nor either mutation at position 40, showed a phenotype alone. This suggests there is a requirement for the Ψ at position 35 under certain conditions .
How is it that worms can do without Ψ at this position? It is possible our assays were incapable of detecting Ψ at this particular position in C. elegans U2 snRNA with the primers that we have used. But we think this is unlikely since we identify Ψs on either side of position 36. It is a formal possibility that CMCT does not react with this particular Ψ in worm U2 snRNA and therefore would not result in a stop to RT, but we believe this is also unlikely. Instead an answer might be found in the differences in consensus sequences seen with C. elegans introns. There is no identified lariat branch point consensus sequence in C. elegans introns and the consensus sequence at the 3' acceptor site is extended and highly conserved [31, 32]. Since there is no branch point consensus in worms, there may be no requirement for a Ψ at position 36 in C. elegans U2 snRNA. In C. elegans U2 snRNP may be more closely associated with the 3' splice site since it has been found that the U2 associated factor (U2AF) is associated with this region of the intron rather than the lariat branch point .
Of the spliceosomal snRNAs, the modifications on U5 snRNA have been determined from the largest number of species . One position (43, in human U5 snRNA numbering) is converted to Ψ in all of the U5 snRNAs where Ψ has been found (Fig. 4). In addition, many U5 snRNAs, C. elegans U5 snRNA included, also have a Ψ at position 46 (Fig. 4). The nucleotide sequence in the loop is highly conserved and is critical for the function of U5 snRNA in the splicing of pre-mRNA [30, 39, 40]. However, the position of Ψ in the stem is not highly conserved, except for a tendency to be located near the ends of the stem (Fig. 4). In tRNAs, Ψs located at the ends of stems are thought to stabilize base-pairing and therefore strengthen the stem . This could be the reason the actual position is not conserved, only the presence of the Ψ in the stem. Interestingly, S. cerevisiae U5 snRNA does not have a Ψ in the stem, only at position 43 in the loop. This yeast has a U5 snRNA that can be folded into a different structure from the other U5 snRNAs . It has an additional stem loop that could have a stabilizing effect on the stem-loop shown in Fig. 4, thereby abrogating the need for the presence of Ψ in the stem in U5 snRNA of S. cerevisiae.
C. elegans U1 snRNA has two uridines at positions 5 and 6, in this region of U1 snRNA that is essential for the function of the splicing factor, but only the uridine at position 5 is converted to Ψ. Many species, including vertebrates, Drosophila, and S. cerevisiae, also have two uridines at these positions but both are converted to Ψ. However, algae and S. pombe U1 snRNAs have two uridines, and Ψ appears only at the position nearest the 5' end of the RNA .
S. pombe, and S. cerevisiae U4 snRNAs have no detectable Ψs [26, 29], whereas vertebrates, Drosophila, and V. faba (bean), all have several Ψs in their U4 snRNAs . One of the three Ψs found in rat U4 snRNA (at position 4) is in a portion of U4 snRNA that is predicted to interact with U6 snRNA, suggesting the presence of Ψ in this region of U4 snRNA could strengthen the interaction. An equivalent Ψ is not present in C. elegans U4 snRNA but the Ψ at position 62, a Ψ that is found in no other sequenced U4 snRNA, is in an area that is predicted to participate in a second intermolecular hybridization with C. elegans U6 snRNA (see Fig. 5B). This A-Ψ base pair is in the middle of three G-U base pairs and so would lend greater stability to the stem formed by U4 and U6 snRNAs. This same snRNA-snRNA interaction is predicted to have only one G-U base pair with mammalian U4 and U6 snRNAs . The A residue in C. elegans U6 snRNA that the Ψ at position 62 of U4 snRNA pairs with is the same residue that is predicted to base pair with the Ψ 28 of U2 snRNA (Fig. 5A), providing evidence of the need to strengthen each of the snRNA-snRNA interactions that involve this region of U6 snRNA.
The total number of Ψs found in the snRNAs of C. elegans is significantly higher than the minimal amount found in yeasts but it is lower than that seen in sequenced vertebrate snRNAs. When the actual sites of modification on C. elegans snRNAs are compared with other sequenced snRNAs most of the positions correspond to modifications found in other species. However, two of the positions modified on C. elegans snRNAs are unique, one at position 28 on U2 snRNA and one at position 62 on U4 snRNA. Both of these modifications are in regions of these snRNAs that interact with U6 snRNA either in the spliceosome or in the U4/U6 small nuclear ribonucleoprotein particle (snRNP). These Ψs and may be involved in strengthening the intermolecular association of the snRNAs.
The determination of the Ψ residues in the spliceosomal snRNAs of C. elegans will speed the identification of enzymes and cofactors that are involved in the modification of these uridine residues. The location of the modifications will also help in the identification of those cofactors by providing sequences that can be used to predict guide sequences in the snoRNAs. Once we can identify cofactors we will be able to use the powerful genetics of C. elegans to mutate the cofactors and affect the formation of Ψ at any position in the snRNAs, especially those that might be critical for the function of the splicing cofactors.
All enzymes and the fmole® Sequencing Kit were purchased from Promega Corporation (Madison, Wisconsin) except for Taq DNA polymerase, which was purchased from Fisher Scientific. The knockout of the C. elegans gene that codes for the homologue of Pseudouridine synthase 1 (Pus1p; strain VC110, W06H3.2 (gk38)) was provided by the C. elegans Reverse Genetics Core Facility at the University of British Columbia, which is funded by the Canadian Institute for Health Research, Genome Canada, and Genome BC. This strain was characterized in an earlier publication .
The snRNA genes from C. elegans were amplified using the polymerase chain reaction (PCR; [45, 46]) from genomic DNA using the following primers: for U1 snRNA, 5'AAACTTACCTGGCTGGGGG3' (U1For) and 5'TTCAGGGCCGCGCGCACGC3' (U1RevA); for U2 snRNA, 5'ATCGCTTCTTCGGCTTATTAGC3' (U2For) and 5'ACTGGGCCGAGCCCGGCAGC3' (U2RevA); for U4 snRNA, 5'AGCTTTGCGCTGGGGCGATAACG3' (U4For) and 5'TTCTGCCTCCTAGAGGCGTTC3' (U4RevA); for U5 snRNA, 5'AACTCTGGTTCCTCTGCATT3' (U5For) and 5'TGACCCGCTTTCTCAAGGAG3' (U5RevA); and for U6 snRNA, 5'GTTCTTCCGAGAACATATAC3'(U6For) and 5'AAAAATTTGGAACGCTTCACG3' (U6RevA). The fragments were gel purified, inserted into pGEMT, and sequenced. The sequences of the inserts matched that of the published snRNA genes from C. elegans .
Isolation of total RNA from worms and assay for Ψ
Total RNA from N2 worms grown at 20°C on Nematode Growth Media plates was isolated as described . Total RNA (10 μg) was treated with 0, 0.041, or 0.167 M 1-cyclohexyl-3(2-morpholinoethyl) carbodi-imide metho-p-toluenesulphonate (CMCT, Aldrich) for 15 minutes at 37°C, precipitated, and treated with sodium bicarbonate as described [34, 35]. These treated RNAs (1 μg) were used in primer extension reactions using AMV reverse transcriptase and 32P-end-labeled primers as described  and the products separated on denaturing (8.3 M urea) 10% polyacrylamide gels (19:1; acrylamide:bis-acrylamide). Sequencing reactions using the same labeled primers were electrophoresed along with the primer extension reactions [35, 48]. The reverse primers listed above for the cloning protocol were used first and the additional primers were: for U1 snRNA, 5'GGCCTAACCATGGGGATTCC3' (U1RevB); for U2 snRNA, 5' CATTCGAGTGTATACCGTAG 3' (U2RevB), 5'CCGAGTCTTCCCTAGGTTCC 3' (U2RevC) and 5'CCTTTATTACACTCATTCG3' (U2RevD); for U4 snRNA, 5'GCGTATGCCACCCATGTTTC3' (U4RevB) and 5'TAAACGCACCTCGGCAAAGC3' (U4RevC); for U5 snRNA, 5'GTAATACTCAGTAAATGCTCC3'(U5RevB) and 5'CTCAGTAAATGCTCCTTTGC3' (U5RevC); for U6 snRNA, 5'GCGTGTCATCCTTGCGCAGG3' (U6RevB) and 5'GCGCAGGGGCCATGCTAATC3' (U6RevC). The dried gels were exposed to Kodak XAR film for various lengths of time.
This work was supported by a Research and Productive Scholarship grant from the University of South Carolina (J.R.P.) and by a grant to R.W.P. from the National Institutes of Health (HD13465).
- Johnson L, Soll D: In vitro biosynthesis of pseudouridine at the polynucleotide level by an enzyme extract from Escherichia coli. Proc Natl Acad Sci U S A. 1970, 67: 943-950.PubMed CentralView ArticlePubMedGoogle Scholar
- Auffinger P, Westhof E: Appendix 5: Location and distribution of Modified nucleotides in tRNA. Modification and Editing of RNA. Edited by: Grosjean H and Benne R. 1998, 569-576. Washinton, D.C., ASM PressGoogle Scholar
- Massenet SA, Mougin A, Branlant C: Posttranscriptional modifications of the U small nuclear RNAs. Modification and Editing of RNA. Edited by: Grosjean H and Benne R. 1998, 201-227. Washington, D.C., ASM PressView ArticleGoogle Scholar
- Griffey RH, Davis D, Yamaizumi Z, Nishimura S, Bax A, Hawkins B, Poulter CD: 15N-labeled Escherichia coli tRNAfMet, tRNAGlu, tRNATyr, and tRNAPhe. Double resonance and two-dimensional NMR of N1-labeled pseudouridine. J Biol Chem. 1985, 260: 9734-9741.PubMedGoogle Scholar
- Davis DR: Stabilization of RNA stacking by pseudouridine. Nucleic Acids Res. 1995, 23: 5020-5026.PubMed CentralView ArticlePubMedGoogle Scholar
- Davis DR, Poulter CD: 1H-15N NMR studies of Escherichia coli tRNA(Phe) from hisT mutants: a structural role for pseudouridine. Biochemistry. 1991, 30: 4223-4231. 10.1021/bi00231a017View ArticlePubMedGoogle Scholar
- Durant PC, Davis DR: Stabilization of the anticodon stem-loop of tRNALys, 3 by an A+-C base- pair and by pseudouridine. J Mol Biol. 1999, 285: 115-131. 10.1006/jmbi.1998.2297View ArticlePubMedGoogle Scholar
- Yu YT, Shu MD, Steitz JA: Modifications of U2 snRNA are required for snRNP assembly and pre-mRNA splicing. Embo J. 1998, 17: 5783-5795. 10.1093/emboj/17.19.5783PubMed CentralView ArticlePubMedGoogle Scholar
- Zhao X, Yu YT: Pseudouridine in and near the branch site recognition region of U2 snRNA are required for snRNP biogenesis and pre-mRNA splicing in Xenopus oocytes. RNA. 2004, 10: 681-690. 10.1261/rna.5159504PubMed CentralView ArticlePubMedGoogle Scholar
- Segault V, Will CL, Sproat BS, Luhrmann R: In vitro reconstitution of mammalian U2 and U5 snRNPs active in splicing: Sm proteins are functionally interchangeable and are essential for the formation of functional U2 and U5 snRNPs. Embo J. 1995, 14: 4010-4021.PubMed CentralPubMedGoogle Scholar
- Donmez G, Hartmuth K, Luhrmann R: Modified nucleotides at the 5' end of human U2 snRNA are required for spliceosomal E-complex formation. RNA. 2004, 10: 1925-1933. 10.1261/rna.7186504PubMed CentralView ArticlePubMedGoogle Scholar
- Newby MI, Greenbaum NL: A conserved pseudouridine modification in eukaryotic U2 snRNA induces a change in branch-site architecture. RNA. 2001, 7: 833-845. 10.1017/S1355838201002308PubMed CentralView ArticlePubMedGoogle Scholar
- Newby MI, Greenbaum NL: Sculpting of the spliceosomal branch site recognition motif by a conserved pseudouridine. Nat Struct Biol. 2002, 9: 958-965. 10.1038/nsb873View ArticlePubMedGoogle Scholar
- Xu D, Greenbaum NL, Fenley MO: Recognition of the spliceosomal branch site RNA helix on the basis of surface and electrostatic features. Nucleic Acids Res. 2005, 33: 1154-1161. 10.1093/nar/gki249PubMed CentralView ArticlePubMedGoogle Scholar
- Valadkhan S, Manley JL: Characterization of the catalytic activity of U2 and U6 snRNAs. RNA. 2003, 9: 892-904. 10.1261/rna.5440303PubMed CentralView ArticlePubMedGoogle Scholar
- Motorin Y, Keith G, Simon C, Foiret D, Simos G, Hurt E, Grosjean H: The yeast tRNA:pseudouridine synthase Pus1p displays a multisite substrate specificity. RNA. 1998, 4: 856-869. 10.1017/S1355838298980396PubMed CentralView ArticlePubMedGoogle Scholar
- Chen J, Patton JR: Cloning and characterization of a mammalian pseudouridine synthase. RNA. 1999, 5: 409-419. 10.1017/S1355838299981591PubMed CentralView ArticlePubMedGoogle Scholar
- Becker HF, Motorin Y, Planta RJ, Grosjean H: The yeast gene YNL292w encodes a pseudouridine synthase (Pus4) catalyzing the formation of psi55 in both mitochondrial and cytoplasmic tRNAs. Nucleic Acids Res. 1997, 25: 4493-4499. 10.1093/nar/25.22.4493PubMed CentralView ArticlePubMedGoogle Scholar
- Lecointe F, Simos G, Sauer A, Hurt EC, Motorin Y, Grosjean H: Characterization of yeast protein Deg1 as pseudouridine synthase (Pus3) catalyzing the formation of psi 38 and psi 39 in tRNA anticodon loop. J Biol Chem. 1998, 273: 1316-1323. 10.1074/jbc.273.3.1316View ArticlePubMedGoogle Scholar
- Chen J, Patton JR: Pseudouridine Synthase 3 from Mouse Modifies the Anticodon Loop of tRNA. Biochemistry. 2000, 39: 12723-12730. 10.1021/bi001109mView ArticlePubMedGoogle Scholar
- Patton JR, Padgett RW: Caenorhabditis elegans pseudouridine synthase 1 activity in vivo: tRNA is a substrate but not U2 small nuclear RNA. Biochem J. 2003, 372: 595-602. 10.1042/BJ20021938PubMed CentralView ArticlePubMedGoogle Scholar
- Behm-Ansmant I, Urban A, Ma X, Yu YT, Motorin Y, Branlant C: The Saccharomyces cerevisiae U2 snRNA:pseudouridine-synthase Pus7p is a novel multisite-multisubstrate RNA:Psi-synthase also acting on tRNAs. RNA. 2003, 9: 1371-1382. 10.1261/rna.5520403PubMed CentralView ArticlePubMedGoogle Scholar
- Ganot P, Jady BE, Bortolin ML, Darzacq X, Kiss T: Nucleolar Factors Direct the 2'-O-Ribose Methylation and Pseudouridylation of U6 Spliceosomal RNA. Mol Cell Biol. 1999, 19: 6906-6917.PubMed CentralView ArticlePubMedGoogle Scholar
- Jady BE, Kiss T: A small nucleolar guide RNA functions both in 2'-O-ribose methylation and pseudouridylation of the U5 spliceosomal RNA. Embo J. 2001, 20: 541-551. 10.1093/emboj/20.3.541PubMed CentralView ArticlePubMedGoogle Scholar
- Zhao X, Li ZH, Terns RM, Terns MP, Yu YT: An H/ACA guide RNA directs U2 pseudouridylation at two different sites in the branch point recognition region in Xenopus oocytes. RNA. 2002, 8: 1515-1525.PubMed CentralPubMedGoogle Scholar
- Massenet S, Motorin Y, Lafontaine DL, Hurt EC, Grosjean H, Branlant C: Pseudouridine mapping in the Saccharomyces cerevisiae spliceosomal U small nuclear RNAs (snRNAs) reveals that pseudouridine synthase pus1p exhibits a dual substrate specificity for U2 snRNA and tRNA. Mol Cell Biol. 1999, 19: 2142-2154.PubMed CentralView ArticlePubMedGoogle Scholar
- Ma X, Zhao X, Yu YT: Pseudouridylation (Psi) of U2 snRNA in S. cerevisiae is catalyzed by an RNA-independent mechanism. EMBO J. 2003, 22: 1889-1897. 10.1093/emboj/cdg191PubMed CentralView ArticlePubMedGoogle Scholar
- Ma X, Yang C, Alexandrov A, Grayhack EJ, Behm-Ansmant I, Yu YT: Pseudouridylation of yeast U2 snRNA is catalyzed by either an RNA-guided or RNA-independent mechanism. Embo J. 2005, 24: 2403-2413. 10.1038/sj.emboj.7600718PubMed CentralView ArticlePubMedGoogle Scholar
- Gu J, Patton JR, Shimba S, Reddy R: Localization of modified nucleotides in Schizosaccharomyces pombe spliceosomal small nuclear RNAs: modified nucleotides are clustered in functionally important regions. RNA. 1996, 2: 909-918.PubMed CentralPubMedGoogle Scholar
- Reddy R, Busch H: Small nuclear RNAs: RNA sequences, structure, and modifications. Structure and function of major and minor snRNPs. Edited by: Birnstiel M. 1988, 1-37. Berlin, Springer VerlagGoogle Scholar
- Blumenthal T, Steward K: RNA Processing and Gene Structure. C elegans II. Edited by: Riddle DL, Blumenthal T, Meyer BJ and Priess JR. 1997, 117-145. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory PressGoogle Scholar
- Hollins C, Zorio DA, MacMorris M, Blumenthal T: U2AF binding selects for the high conservation of the C. elegans 3' splice site. Rna. 2005, 11: 248-253. 10.1261/rna.7221605PubMed CentralView ArticlePubMedGoogle Scholar
- Madhani HD, Guthrie C: Dynamic RNA-RNA interactions in the spliceosome. Annu Rev Genet. 1994, 28: 1-26. 10.1146/annurev.ge.28.120194.000245View ArticlePubMedGoogle Scholar
- Bakin AV, Ofengand J: Mapping of pseudouridine residues in RNA to nucleotide resolution. Methods Mol Biol. 1998, 77: 297-309.PubMedGoogle Scholar
- Baumstark T, Ahlquist P: The brome mosaic virus RNA3 intergenic replication enhancer folds to mimic a tRNA TpsiC-stem loop and is modified in vivo. RNA. 2001, 7: 1652-1670.PubMed CentralPubMedGoogle Scholar
- Thomas J, Lea K, Zucker-Aprison E, Blumenthal T: The spliceosomal snRNAs of Caenorhabditis elegans. Nucleic Acids Res. 1990, 18: 2633-2642.PubMed CentralView ArticlePubMedGoogle Scholar
- Del Campo M, Kaya Y, Ofengand J: Identification and site of action of the remaining four putative pseudouridine synthases in Escherichia coli. RNA. 2001, 7: 1603-1615.PubMed CentralPubMedGoogle Scholar
- Del Campo M, Recinos C, Yanez G, Pomerantz SC, Guymon R, Crain PF, McCloskey JA, Ofengand J: Number, position, and significance of the pseudouridines in the large subunit ribosomal RNA of Haloarcula marismortui and Deinococcus radiodurans. Rna. 2005, 11: 210-219. 10.1261/rna.7209905PubMed CentralView ArticlePubMedGoogle Scholar
- Newman A, Norman C: Mutations in yeast U5 snRNA alter the specificity of 5' splice-site cleavage. Cell. 1991, 65: 115-123. 10.1016/0092-8674(91)90413-SView ArticlePubMedGoogle Scholar
- Newman AJ, Norman C: U5 snRNA interacts with exon sequences at 5' and 3' splice sites. Cell. 1992, 68: 743-754. 10.1016/0092-8674(92)90149-7View ArticlePubMedGoogle Scholar
- Yang C, McPheeters DS, Yu YT: Psi35 in the branch site recognition region of U2 small nuclear RNA is important for pre-mRNA splicing in Saccharomyces cerevisiae. J Biol Chem. 2005, 280: 6655-6662. 10.1074/jbc.M413288200View ArticlePubMedGoogle Scholar
- Madhani HD, Guthrie C: A novel base-pairing interaction between U2 and U6 snRNAs suggests a mechanism for the catalytic activation of the spliceosome. Cell. 1992, 71: 803-817. 10.1016/0092-8674(92)90556-RView ArticlePubMedGoogle Scholar
- Davis DR, Veltri CA, Nielsen L: An RNA model system for investigation of pseudouridine stabilization of the codon-anticodon interaction in tRNALys, tRNAHis and tRNATyr. J Biomol Struct Dyn. 1998, 15: 1121-1132.View ArticlePubMedGoogle Scholar
- Wersig C, Bindereif A: Conserved domains of human U4 snRNA required for snRNP and spliceosome assembly. Nucleic Acids Res. 1990, 18: 6223-6229.PubMed CentralView ArticlePubMedGoogle Scholar
- Mullis K, Faloona F, Scharf S, Saiki R, Horn G, Erlich H: Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction. Cold Spring Harb Symp Quant Biol. 1986, 51: 263-273.View ArticlePubMedGoogle Scholar
- Mullis KB, Faloona FA: Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol. 1987, 155: 335-350.View ArticlePubMedGoogle Scholar
- Johnstone IL: C elegans: A practical approach. 1999, 201-225. Molecular Biology, Oxford, Oxford University Press, Hope IA,The Practical Approach Series, Hames BDGoogle Scholar
- Sanger F, Nicklen S, Coulson AR: DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977, 74: 5463-5467.PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.